| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.028 | 0.7 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |